Insulin-Like Growth Factor I (IGF-I) in the Prevention of Complications of Preterm Birth
This study is currently recruiting participants.
Verified January 2013 by Premacure AB
Sahlgrenska University Hospital, Sweden
Lund University Hospital
Karolinska University Hospital
Information provided by (Responsible Party):
First received: March 9, 2010
Last updated: January 13, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2013|
|Estimated Primary Completion Date:||December 2013 (Final data collection date for primary outcome measure)|
Ley D, Hansen-Pupp I, Niklasson A, Domellöf M, Friberg LE, Borg J, Löfqvist C, Hellgren G, Smith LE, Hård AL, Hellström A. Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety. Pediatr Res. 2013 Jan;73(1):68-74. doi: 10.1038/pr.2012.146. Epub 2012 Oct 24.